» Articles » PMID: 38686485

[Research Advances of Mesenchymal Stem Cell in Allergic Rhinitis]

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Allergic rhinitis is a chronic nasal mucosal inflammation characterized by upper airway hyperresponsiveness, involving a variety of immune cells and inflammatory mediators. Drugs, immunotherapy, and surgical operation are the principal treatments at present. The study found that mesenchymal stem cells have the ability of immune regulation and have a promising clinical application in the treatment of allergic rhinitis. In this review, the action mechanism of mesenchymal stem cells, the immunomodulatory effect of mesenchymal stem cells on the key cells of allergic rhinitis, and the challenges of clinical application are reviewed, to provide new directions for the treatment of allergic rhinitis.

References
1.
Zou B, Zhuang R, Sun X, Liang J . Analysis of the expression changes of IL-17+ γδ T cells and Treg cells in bone marrow mesenchymal stem cells targeted therapy for allergic rhinitis. Eur Rev Med Pharmacol Sci. 2021; 25(7):2858-2865. DOI: 10.26355/eurrev_202104_25539. View

2.
Cho B, Kim J, Ha D, Yi Y . Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther. 2018; 9(1):187. PMC: 6042362. DOI: 10.1186/s13287-018-0939-5. View

3.
Lee H, Jung H, Kim D . IDO and CD40 May Be Key Molecules for Immunomodulatory Capacity of the Primed Tonsil-Derived Mesenchymal Stem Cells. Int J Mol Sci. 2021; 22(11). PMC: 8198434. DOI: 10.3390/ijms22115772. View

4.
Zhong H, Fan X, Fang S, Lin Y, Wen W, Fu Q . Human pluripotent stem cell-derived mesenchymal stem cells prevent chronic allergic airway inflammation via TGF-β1-Smad2/Smad3 signaling pathway in mice. Mol Immunol. 2019; 109:51-57. DOI: 10.1016/j.molimm.2019.02.017. View

5.
Khare D, Or R, Resnick I, Barkatz C, Almogi-Hazan O, Avni B . Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes. Front Immunol. 2019; 9:3053. PMC: 6308164. DOI: 10.3389/fimmu.2018.03053. View